IMSYSER AGENTS for VULCAN SILVER LIQUID
This amazing product is developed with Nano technology to create clusters of silver deposits in an existing 'colloidal' silver state(distilled water) with incredible results - a product 1000 times more potent than you average normal Colloidal Silver. Quantum Science explains the exponential silver deposits 1000 times.
A Short Introduction
Neil, an HIV specialist living in Pretoria, partner to the original patent holder in the UK, was kind enough to teach the Imsyser team about the benefits of this amazing product which has been in development and used for various ailments as described below for the past 20 years.
More specifically, tests done at our own CSIR for HIV and Malaria. it is noted that with a universal dose of 2.5mg of this amazing product, 3 weeks into treatment HIV ( no chronic aggressive infections present) may be reversed as the silver manages to penetrate and destroy this viruse!
One of the interesting facts was the fact that it appears that viral loads may change with various treatments but very seldom changes are seen in the CD counts. Not the case for Vulcan Silver, however!!
In the UK test were done more specifically on Hepatitis with incredible results! as was the results of the top 6 chronic infections as experienced in the UK.
Simply put this amazing product is developed with Nano technology to create clusters of silver deposits in an existing 'colloidal' silver state(distilled water) with incredible results - a product 1000 times more potent than you average normal Colloidal Silver. A mere understanding of Quantum Science explains the exponential deposits as opposed to normal production of a simple Colloidal Silver.
For more on the various studies done scroll down for the summary of these trials.
And, best of all there is no potential danger of over-dosing or the old fashioned belief that you could go "blue"! The resultant high in energy release is mere proof of the amazing detox experienced even for the most toxic of constipation cases. Similarly this product is safe for babies and children. In fact, it was found in some of the studies that if the infected HIV mother is treated, the baby is born without the same. This treatment of a mere 1ml might be dropped into any formula for easy treatment from the youngest of ages.
Vulcan Silver is also totally safe for the worst of TB cases - all types of TB. And so the list goes on, as may be noted below.
Enjoy reading up about this amazing healing treatment right here on your doorstep......
Vulcan Silver versus Colloidal Silver.
This is not so much a frequently asked question as it is a frequent misconception. Because colloidal silver has been around for the best part of a century people assume that anything stating colloidal or even nano silver are all pretty much the same thing. That was until Vulcan Silver came along.
Now the easiest way to show you the difference is in an actual in-vitro (petri dish) study. Below you will see a picture taken of a petri dish that was cultivated with bacteria. Micro dots were then submersed into stock colloidal silver and Vulcan Silver Immune Pro. In order micro dot number 1 was soaked in colloidal silver, dot number 2 was VS Immune Pro diluted 100 times, dot 3 was VS Immune Pro diluted 10 times, dot 4 was VS Immune Pro as you would buy it off the shelf and dot number 5 was a control microdot with nothing added as a point of reference.
The top unnumbered dots were identical to the numbered ones. Now, once an antibacterial microdot is placed on the surface of a bacteria smear then it should show a halo or ring of deactivation of the bacteria around it. This is seen most prominently in disk 4. However even at dilutions of 10 and 100 there are rings around the microdot evidence that it is effective in killing the bacteria.
The colloidal silver dot is however indistinguishable from the control dot in that neither has any ring of efficacy around it. Vulcan Silver also has a unique method of the delivery of silver into the body which is truly unique but that would be a whole science lesson on its own.
Vulcan Silver benefits:
- Viral Bacteria
- Parasitic infections
- Anti Inflammatory infections, Autoimmune diseases and related:
Infection, disease and/or disorder
- Viral infections
- Bacterial infections
- Fungal infections
- Parasitic infections
- Cancer and/or respiratory diseases
Viral infection HIV/AIDS related infection,
- Herpes virus infection
- Viral dysentery
- Respiratory syncytial virus
- Dengue fever
- Yellow fever
- Lassa fever
- Arena Virus
- Bunya Virus
- Flavin Virus, Hantavirus
- Rotavirus, Viral Meningitis
- H5N1 Virus (Bird Flu)
- Epstein-Barr Virus
- Dengue Hemorrhagic Fever
- Infant Cytomegalic Virus
- Progressive Multifocal Leukoencephalopathy
- Viral Gastroenteritis
- Cold Sores
- Human papillomavirus
- Viral ear and eye infections
- Bacterial pneumonia
- Escherichia coli (e. coli) infections
- Candida infection
- RSA methicillin resistant Staphylococcus aureus (S, aureus) infection - strain ATCC
- Vancomycin resistant Enterococcus faecalis (E. faecalis) infection - strain #1061
- Salmonella enteritidis (S. enteritidis) infection - strain ATCC #13076,
- Clostridium difficile (C. difficile) infection - strain ATCC #9689
- Pseudomonas aeruginosa (P. aeruginosa) infection - hospital clinical strain.
- Blast mycosis
- Piedra Pityriasis versicolor
- Tinea Barbae
- Tinea Capitis
Vulcan Silver Protocol
Understanding Dosage ratio between protocols
- From earlier experience with VS it is suggested that one cannot overdose.
- In terms of cost, a double dose would be more expensive, however it is reported that a double dose will heave better results.
- The reason for suggesting the 2.5 dose is purely in relation to cost. This suggested does allowance is intended to allow for a constant circulation silver in the body to better facilitate its healing properties.
- From examples: An entire bottle has been consumed in an attempt to fight a common cold. It has been said that this approach provides a faster action on helping a person overcome the effects of a common flu within hours.
- Another reported advantage is that Vulcan Silver does not interact with any current medication prescription medication. Rather the effects of Vulcan Silver promotes the effectiveness of prescription drugs.
- As Vulcan Silver is a natural product there are not added toxic compounds that would negatively impact the human body.
Vulcan Silver As An Treatment for Blepharitis & Pink Eye
The clear liquid in the Vulcan Silver bottle is chemically synthesized in a laboratory. And is extremely effective as an eye drop in the treatment of blepharitis and Pink eye.
Blepharitis symptoms and signs include: Watery eyes. Red eyes. A gritty, burning or stinging sensation in the eyes. Eyelids that appear greasy. Itchy eyelids. Red, swollen eyelids. Flaking of the skin around the eyes. Crusted eyelashes upon awakening.
Recommended dose: 1 to 2 drops in each eye 2-6 times daily. Discontinue treatment as soon as symptoms disappear.
How to dispense the liquid:
1. While the liquid is clear and the settlement is settled at the base of the bottle.
2. Using the clean pipette, expel a small amount of the liquid and gently release a small drop into affected eye.
IN VITRO ANTIMALARIAL ASSAY VULCAN SILVER SAMPLES
Compiled by: Heinrich Hoppe, PhD
24 June 2011
1. Assay Background
The in vitro antimalarial activity of test samples against the 3D7 (chloroquine-sensitive) strain of the malaria parasite, Plasmodium falciparum, is measured by assessing parasite survival after drug exposure using a parasite lactate dehydrogenase (pLDH) colorimetric enzyme assay. pLDH activity is used as a surrogate for parasite levels in the cultures. To distinguish between pLDH and human LDH contained in the host red blood cells, APAD (3-acetylpyridine adenine nucleotide) is used as cofactor for the conversion of lactate to pyruvate instead of NAD. The human enzyme is incapable of using APAD. APADH formed in the reaction reduces nitro blue tetrazolium to a purple formazan product which absorbs at 620nm.
In the standard dose-response assay, 11x3-fold serial dilutions of test samples are added to trophozoitestage parasite cultures (2% parasitaemia, 1% haematocrit) in 96-well plates (duplicate wells for each compound concentration). After 48h incubation, pLDH activity in the wells is determined at 620nm using a
multiwell spectrophotometer. Wells containing uninfected erythrocytes are used as background controls and their mean Abs620 value subtracted from those of test wells. Percentage parasite viability in the test wells is calculated by reference to control wells containing parasites incubated with compound-free medium.
In this assay, IC50s of 1-10μg/mL may be regarded as moderate antimalarial activity, 0.1 – 1 μg/mL as good activity and < 0.1μg/mL as potent activity.
Sample 1 thus has moderate activity, while sample 2 displays good activity.
Moderately active compounds are unlikely to be promising therapeutics, without further modification. The therapeutic potential of compounds with good activity depends on several additional factors. For example, if the compound displays no toxic or other effects on human cells below 100 μg/mL, the therapeutic window may be large enough to warrant further investigation. Moreover, if concentrations of the compound >1 μg/mL can be maintained (and tolerated) for several hours in the blood of human patients after oral administration, antimalarial IC50s of 0.1 - 1μg/mL may be sufficient to result in cure. The latter depends on additional factors, e.g. the stage of the malaria parasite life-cycle that is vulnerable to the compound and how rapidly the compound kills parasites (both may be assessed in in vitro experiments). Due to the resource and infrastructure-poor regions inhabited by populations bearing the burden of malaria, additional factors need to be considered, according to Medicines for Malaria Venture (MMV) and WHO
guidelines. The compound needs to be stable at elevated temperatures for extended periods of time. The compound needs to available as an oral (or suppository, for infants) formulation. The compound needs to be able to completely eradicate parasites in patients after 1-3 doses over a period of 3-5 days. Total cost of treatment per patient should not exceed 1 US$.